ArticleInfection2026
Development and validation of a nomogram for predicting mortality in patients with vertebral osteomyelitis.
Article in Infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nomogram for predicting inadequate treatment response in vertebral osteomyelitis.Annals of medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
STUDY
designRetrospective study.
methodsFrom January 2019 to January 2025, patients diagnosed with vertebral osteomyelitis at Shandong Public Health Clinical Center were enrolled. Clinical data were analyzed using Least Absolute Shrinkage and Selection Operator (LASSO) regression and multivariable logistic regression to identify risk factors. A prognostic nomogram was developed and evaluated for discrimination using the area under the receiver operating characteristic curve (AUC), calibration using the Hosmer-Lemeshow test and calibration curves, clinical utility through decision curve analysis, and robustness with 500 bootstrap resamples for internal validation. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated at the optimal cutoff.
resultsOf 248 patients, 55 (22.17%) died within 1 year. Eight independent risk factors were identified: renal insufficiency, higher Charlson Comorbidity Index, elevated C-reactive protein and white blood cell levels, multifocal vertebral osteomyelitis, pneumonia, poor cardiac function, and poor wound healing. The nomogram demonstrated excellent discrimination (AUC: 0.957; 95% CI 0.929-0.985), confirmed by bootstrap validation (AUC: 0.946; 95% CI 0.915-0.977). At a cutoff of 0.135, it achieved 82.5% sensitivity, 93.3% specificity, 88.7% positive predictive value, 81.9% negative predictive value, and 92.7% accuracy. Calibration was adequate (Hosmer-Lemeshow P = 0.750), and decision curve analysis confirmed clinical benefit.
conclusionsThis pioneering nomogram accurately predicts 1-year mortality in vertebral osteomyelitis, facilitating personalized clinical management.
Indexed as
Identifiers
41758454What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.